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Resonance Raman (RR) and absorption spectroscopic studies of purified rabbit liver cytochromes P-450 show that the 
form 2 isomer (LM2) but not the form 4 isomer (LM4) forms a long-lived complex with halothane after dithionite reduc- 
tion, absorbing light at 470 nm, in which ferric 6-coordinated heme iron in the low-spin configuration is liganded to 
2-chloro-l,l-difluoroethylene. The RR data exclude the possibility that the CF,CHCl- carbanion is a ligand and are 
consistent with the involvement of an active-site pocket in the cytochrome P-450 polypeptide. 
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1. INTRODUCTION 
Many chemical substances form catalysis- 
dependent complexes with cytochrome P-450 
(reviews [ 1,2]) detectable by special absorbances 
between 440 and 480 nm. This diagnostic feature is 
in many cases the only structural parameter of 
these complexes that is known and is used to define 
their structure by comparison with porphyrin 
model complexes. More is known about the struc- 
ture of such ‘intermediate complexes’ originating 
in the course of reductive dehalogenation of 
halocarbons [3,4], in particular of a halothane- 
derived complex which exhibits unique stability in 
comparison with other intermediate complexes of 
cytochrome P-450 with halocarbons (e.g. CCL) 
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[5], and which has been regarded as a complex be- 
tween ferric 6-coordinated heme iron in the low- 
spin configuration and the CF$HCl- carbanion 
[6]. It was assumed that this complex degrades via 
p-elimination to form 2-chloro-l , l-difluoro- 
ethylene, a well known product of halothane in 
vivo and in vitro [6-81. 
In this study on the structure of the halothane 
complex, we have used resonance Raman (RR) 
spectroscopy which can provide unambiguous in- 
formation on the oxidation, spin and ligation state 
of the heme iron [9]. This technique and the use of 
purified isoenzymes 2 (LM2) and 4 (LM4) of 
cytochrome P-450 contribute to the elucidation of 
the enzymatic process of the reductive branch of 
halothane biotransformation. Previous studies 
have shown that the halothane complex forms 
readily with the major phenobarbital-inducible 
isoenzyme of cytochrome P-450 LM2 [5, lo] which 
is consistent with the fact that this isozymic form 
also generates the greatest amount of 2-chloro-l , I- 
difluoroethylene when incubated with halothane 
[ 111. The present results exclude the possibility of a 
carbanion complex and suggest hat 2-chloro-l , l- 
difluoroethylene is the complexing ligand. 
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2. MATERIALS AND METHODS A 
P-450 isoenzymes LM2 (13.5 nmol/mg) and LM4 
(15.2 nmol/mg) were purified from liver microsomes of pheno- 
barbital-treated rabbits [12] and solubilized in Emulgen 913 
(Kao Chemicals, Tokyo). All samples contained 20% (v/v) 
glycerol, 0.2% Emulgen 913 and 150 mM potassium phosphate 
buffer (pH 7.3). The P-450-halothane complex (P-450-Hal) 
was prepared by adding a halothane-saturated glycerol-buffer 
solution (0.4 ml) to a suspension of P-450 (0.4 ml, lo-’ M). 
Reduction of P-450-Hal was achieved by adding a small amount 
of dithionite (Merck, Darmstadt) to the solution. Halothane 
was bought from Ayerst Labs (New York). 
Absorption spectra were recorded with a Shimadzu UV240 
spectrometer. RR spectra were excited with the 406 and 476 nm 
lines of a Krf and Ar+ laser, respectively, with a power of 
30 mW or less at the sample. The RR signals were accumulated 
by repetitive scanning. Details of the equipment are described in 
[13]. The spectral band width was 4 cm-‘. The samples were 
deposited in a rotating cuvette in order to minimize thermal 
heating or photodegradation. 
Before and after RR experiments the integrity of the sample 
was checked by the absorption spectra. 
Fig. 1. Absolute absorption spectra of cytochrome P-450,, LM2 
(A), after binding of halothane (B) and after reduction of the 
cytochrome P-450 LMZ-halothane complex with dithionite (C). 
3. RESULTS 
Excitation of the RR spectrum at 406 nm in the 
Soret transition of cytochrome P-450 LM2 (see 
fig. 1A) predominantly enhances the totally sym- 
metric stretching vibrations of the porphyrin 
macrocycle [9]. The strongest RR band in the fre- 
quency range displayed in fig.2A is ~4 at 1371 cm-’ 
which is known to be sensitive to the oxidation 
state of the heme iron. The observed frequency is 
typical for a ferric heme while upon reduction this 
band shifts down significantly. The frequencies of 
most of the bands above 1400 cm-’ have been cor- 
related with the core size of the porphyrin, i.e. the 
center-to-pyrrole-nitrogen distance d(Ct-N). These 
are the bands at 1500 (~g), 1553 (v~s), 1562 (vii), 
1580 (vz), 1602 (VW), and 1635 cm-’ (YK,) [9,14]. 
(P-4500,-Hal) induces a slight blue shift in the 
Soret absorption band (fig.1) as is observed for 
type-1 substrate binding [ 151. This is due to the par- 
tial population of the five-coordinated high-spin 
(5cHS) state. The RR spectrum of this complex 
(fig.3A) does not reveal significant differences 
from that of the substrate-free nzyme (fig.2A). 
However, minor spectral changes can be visualized 
by a difference spectrum (spectrum in fig.3A - 
spectrum in fig.2A) which is displayed in fig.2B. 
Here it can be seen that upon halothane binding, 
bands near 1491, 1574, 1597 and 1628 cm-’ have 
appeared at the expense of those near 1501, 1582, 
1606 and 1638 cm-‘, respectively. The positive 
peaks in the difference spectrum correspond to the 
marker bands ~3, ~2, ~3~ and VIO of the 5cHS state 
(table l), reflecting a small change of the spin state 
equilibrium [ 161. 
Since d(Ct-N) is determined by the oxidation, 
spin and ligation state, the frequencies of these 
bands can be used to identify the electronic con- 
figuration of the central metal ion (spin state 
marker bands). The comparison with the charac- 
teristic values for different spin and ligation states 
(table 1) clearly shows that cytochrome P-450 LM2 
(oxidized) is in the six-coordinated low-spin (6cLS) 
configuration. There is no evidence of even a small 
contribution from a high-spin (HS) configuration 
which should give rise to bands at down-shifted fre- 
quencies (see table 1). 
Binding of halothane to cytochrome P-450 LM2 
Dithionite reduction of the halothane-bound 
cytochrome P-450 LM2 produces significant 
changes in the absorption spectrum (fig.lC). The 
Soret band has split into two components at 423 
and 470 nm of nearly equal oscillator strength. The 
RR spectrum of this complex (P-450-Hal),,d com- 
pared to P-4500X-Hal excited at 406 nm (fig.3B) ex- 
hibits most conspicuously a general decrease in ab- 
solute RR intensity and a particular lowering of the 
relative intensity of ~4 (1371 cm-‘) with respect o 
the other bands (fig.3A). This can easily be 
understood, since at Soret band excitation the RR 
intensity of the totally symmetric modes, in par- 
ticular of ~4, is determined by the oscillator 
strength [17] which is much lower for the 423 nm 
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Fig.2. RR spectrum of cytochrome P-450., LM2 (19pM) excited 
at 406 nm (A). The inset (B) displays the difference between the 
RR spectrum of cytochrome P-450,, LM2 after and before 
halothane binding (fig.3A-panel A, this figure). 
band of (P-450-Ha&d than for the Soret band of 
P-450,,-Hal (see fig. 1). The frequency of v4 (1372 
cm-‘) is not very different from that of the oxi- 
dized P-450-Hal complex, indicating that the ox- 
idation state of the heme iron (Fe3’) is preserved in 
this complex. This interpretation is substantiated 
by a comparison with the values of v4 of reduced 
protoporphyrin complexes (1358 cm-‘) 1141 or of 
the reduced, substrate-free, cytochrome P-450 
LM2 (1341 cm-‘), which are shifted to much lower 
frequencies (table 1). Also, the spin state marker 
bands ~3 (1501 cm-‘), ~11 (1564 cm-‘), ~2 (1579 
cm-‘), ~37 (1604 cm-‘), and vro (1635 cm-‘) appear 
at positions which unambiguously point to a ferric 
6cLS configuration. It should be pointed out that 
most of the frequencies are higher than in P-450,,, 
indicating replacement of the original axial ligand 
in the 6th position. 
During the RR experiment a slow growing-in of 
a band near 1360 cm-’ was observed which was ac- 
companied by an intensity decrease of the 1372 
cm-’ band. Based on the absorpton spectra (CO 
complex) the intensity of the 1360 cm-’ band could 
be correlated with the amount of P-450& which 
was formed during the RR experiment. Based on 
comparative studies with different laser powers, 
excitation wavelengths and dithionite concentra- 
tions, it was concluded that conversion to P-420 
was induced by primary or secondary products of 
the photodecomposed ithionite. 
Excitation of the RR spectrum of (P-450-Hal),,d 
in the low-energy component of the Soret band at 
476 nm gives a similar spectrum (not shown). 
However, due to the strong background, it was on- 
Table 1 
Frequencies (cm-i) of the oxidation and spin state marker bands of various states of P-450 and iron protoporphyrin model compounds” 
Mode P-450,, Fe’+PP(ImH)zb P-450,,-Hal’ Fe3+PPClb (P-45O-Hal),d (P-450-D&dd p-450rcde 
(6cLS) (5cHS) 
v4 1371 1373 1370 1373 1372 1376 1341 
y3 1500 1502 1491 1491 1501 1503 - 
J’38 1553 1554 1555 1533 1549 1553 - 
VII 1562 1562 1564 1553 1564 1565 1559 
Y2 1580 1579 1574 1570 1579 1588 1586 
Y37 1602 1602 1597 1591 1604 - - 
YIO 1635 1640 1628 1626 1635 1639 1606 
a The subscripts ox and red refer to the oxidation state of the heme iron (Fe 3+ Fe2+); 6cLS, six-coordinated low-spin; ScHS, five- , 
coordinated high-spin 
b Data for the bis(imidazole) complex (Fe3+PPIMH)z) and the p-0x0 dimer (Fe’+PPCl) of iron protoporphyrin IX are adopted from 
1131 
' Bands of the high-spin component of the oxidized cytochrome P-450 LM-halothane complex (P-450,x-Hal) as derived from the dif- 
ference spectrum in fig. 2A 
d Data for the reduced 0x0 complex of cytochrome P-450-CAM adopted from [21]. 
’ From [19] 
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Fig.3. RR spectra of the cytochrome P-450 LMZ-halothane 
complex before (A) and after dithionite reduction (B) excited at 
406 nm. 
ly possible to identify the strongest band at 1372 
cm-’ (~4). 
The halothane-derived complex or a type-I- 
binding spectrum of cytochrome P-450 LM4 could 
not be detected in another series of absorption 
measurements. 
4. DISCUSSION 
Both absorption as well as RR spectroscopic 
measurements demonstrate type I binding of 
halothane to oxidized cytochrome P-450 LM2. As 
in the case of benzphetamine, the classic type I 
substrate, the concomitant shift of the spin state 
equilibrium from the 6cLS to 5cHS configuration 
is very small for LM2 solubilized in Emulgen 913 
HeI. 
The complex formed from halothane upon 
dithionite as well as enzymic reduction was former- 
ly assumed, on the basis of comparative EPR and 
absorption spectroscopic studies of model com- 
plexes and liver microsomes, to be a 6cLS complex 
of heme ferric iron with the carbanion CF&HCI- 
and thiolate as opposing axial ligands [6]. Thereby, 
the previous suggestions [4] of an Fe2+-CHCF3 
(carbene) complex could be ruled out. 
Our RR data confirm that the heme iron is in the 
6cLS configuration, however, they can be recon- 
ciled with neither the carbene nor the carbanion 
complex. The frequency of the RR bound ~4, 
whose main contributions are the G-N stretching 
vibrations, is highly sensitive to delocalization of 
the electrons in the porphyrin macrocycle [18]. The 
G-N stretching force constants become weaker 
and thus the frequency of v4 decreases by increas- 
ing the electron density in the antiboding *-orbitals 
of the porphyrin via back-donation from the d,- 
orbitals of the central metal ion. Since back- 
donation is stronger in Fe2+ than in Fe3+, v4 shifts 
down upon reduction by about lo-15 cm-‘. For ex- 
ample, ~4 is at 1373 cm-’ in methemoglobin (Fe3’) 
but at 1358 cm-’ in deoxyhemoglobin (Fe2’). This 
effect can be significantly enhanced when one axial 
ligand exhibits high basicity like thiolate [18,19] 
which in (P-45O),,d lowers ~4 to 1341 cm-‘. In 
(P-450-Hal),d, however, ~4 is at 1373 cm-’ which 
is even higher than in (P-45O)0,. Thus, the possi- 
bility of a ferrous carbene can be unambiguously 
ruled out. Also, the assignment to the ferric carba- 
nion complex [20] is highly unlikely. The coordina- 
tion of the heme iron by two strong electron donors 
(thiolate, carbanion) should lead to a significant 
decrease in the ~4 frequency. Thus, one must con- 
clude that the second axial ligand in (P-450-Ha&d 
is an electron acceptor. This conclusion is in line 
with the RR data on the carbon monoxide [19] or 
dioxygen [20] complexes of the reduced P-450, 
which both reveal a frequency upshift of ~4 by 
25-35 cm-’ compared to (P-45t&d. Both ligands 
possess empty a*-orbitals which can accept elec- 
tron density competing with the r*-orbitals of the 
porphyrin. Thus, the respective frequencies of v4 
are found to be as high as 1366 and 1376 cm-‘. It 
is important to point out that a split Soret band, 
which had been taken as the main evidence for 
thiolate-carbanion ligation, is also found in the ab- 
sorption spectrum of the (P-450-Hal),,d as well as 
the CO complex of (P-45O),d [22]. This implies 
that the electronic spectrum of the (P-450-Ha& 
complex is also in line with a coordination con- 
figuration including a strong electron donor 
(thiolate) and electron acceptor. 
At present, we are unable to identify unam- 
biguously the second axial ligand. However, 
18 
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among the intermediates which are possibly 
formed during reduction of halothane, there is no 
candidate which might serve as an electron accep- 
tor except the final product, CFz= CHCl, itself. 
Therefore, we tentatively assign the 2nd axial 
ligand to this olefin (fig.4). As in the case of 02 or 
CO, electron density may be transferred into the 
empty a*-orbital of this molecule so that ~4 in- 
creases compared to (P-450-Hal),,. Ligation of 
chlorodifluoroethylene instead of a carbanion pro- 
vides a better explanation for the stability of the 
complex and the failure to detect CH&lHD during 
reductive dehalogenation of halothane in the 
presence of D20 [23] (see fig.4). This may imply 
that defluorination, favored ,by hyperconjugation 
of the C-Fa bond [24], takes place during transfer 
of a second electron. As further evidence that 
reduction is complete, it has been reported that, 
once formed, the complex is sufficiently stable to 
allow the removal of all substrate and reductant. 
Following this, if the complex is disrupted, 
2-chloro-l , 1 -difluoroethylene is obtained as the 
major product [5]. 
Formation of the (P-450-Ha&d complex is a 
unique property of LM2. Attempts to detect this 
complex in LM4 failed, indicating that only the 
7’ 1 -C-H P-450 
. 
r F I 7’ 1 
specific protein environment of the heme in LM2 
satisfies the structural requirements for the forma- 
tion and stability of this complex. This may be 
achieved due to nestling of the CK group in the 
02-binding site, which may form a shape in 
cytochrome P-450 LM2 similar to the pocket 
observed in cytochrome P-450-CAM by X-ray 
crystallography [25]. In this way, CF2 = CHCl may 
be fixed in a specific orientation with respect o the 
porphyrin leading to an electronic interaction with 
the heme iron. It may be difficult to synthesize 
model compounds which feature this structural 
specificity. 
It was not possible to detect the (P-450-Ha& 
complex upon direct addition of CF2 = CHCl to 
(P-450),& This may be explained as follows: only 
CF2 = CHCl originating in situ would be able to in- 
duce and use this favorable protein conformation 
near the heme iron and not external CFz=CHCl 
intruding through the cleft amenable to substrate 
access. 
While there has been some speculation regarding 
the possibility that a radical and a carbanion may 
be formed as cytotoxic intermediates in the reduc- 
tive metabolism of halothane, these studies of the 
halothane complex offer a more complete picture; 
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Fig.4. Formation and breakdown of the postulated cytochrome P-450 LM2-halothane intermediate complex. 
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they indicate that the production of the carbanion 
as a toxic intermediate is highly unlikely (see fig.4). 
Furthermore, as the formation of the complex ap- 
pears to be a unique feature of phenobarbital- 
induced forms of the cytochrome corresponding to 
cytochrome P-450-LM2, it is tempting to suppose 
an involvement of this complex in the liver-toxic ef- 
fects of halothane seen only in the phenobar- 
bital-induced male hypoxic rat. 
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